Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Feeding disorder, Illness, Nausea, Pneumonia
Clinical narrative: diagnosed with COVID-19; When got first shot, arm hurt; Felt nauseous; every time he threw up; Couldn't eat after first dose;; When got first shot, was sick; This spontaneous case was reported by a consumer and describes the occurrence of FEEDING DISORDER (Couldn't eat after first dose;), ILLNESS (When got first shot, was sick), COVID-19 (diagnosed with COVID-19), VACCINATION SITE PAIN (When got first shot, arm hurt) and NAUSEA (Felt nauseous) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    In 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In 2021, the patient experienced FEEDING DISORDER (Couldn't eat after first dose;), ILLNESS (When got first shot, was sick), VACCINATION SITE PAIN (When got first shot, arm hurt), NAUSEA (Felt nauseous) and VOMITING (every time he threw up). On 23-Jan-2022, the patient experienced COVID-19 (diagnosed with COVID-19). The patient was treated with PARACETAMOL (TYLENOL 8 HOUR) for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, FEEDING DISORDER (Couldn't eat after first dose;), ILLNESS (When got first shot, was sick), VACCINATION SITE PAIN (When got first shot, arm hurt), NAUSEA (Felt nauseous) and VOMITING (every time he threw up) had resolved and COVID-19 (diagnosed with COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Jan-2022, Pneumonia: negative (Negative) Negative. On 23-Jan-2022, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient visited to hospital on 23-JAN-2022.  No concomitant medication was reported by the reporter.  Company comment: This case concerns a 21-year-old male patient with no medical history reported, who experienced non-serious unexpected AESI of COVID-19, that occurred after the 1st dose of the mRNA-1273 . The exact time to onset was not provided. The rechallenge was not applicable due to nature of the event of COVID-19 and no information on the 2nd dose. Based on the current available information, the mRNA-1273 does not contain a virus capable of causing COVID-19 infection after vaccination. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This case concerns a 21-year-old male patient with no medical history reported, who experienced non-serious unexpected AESI of COVID-19, that occurred after the 1st dose of the mRNA-1273 . The exact time to onset was not provided. The rechallenge was not applicable due to nature of the event of COVID-19 and no information on the 2nd dose. Based on the current available information, the mRNA-1273 does not contain a virus capable of causing COVID-19 infection after vaccination. The benefit-risk relationship of mRNA-1273 is not affected by this report.